Structural Formula (Opzelura 1)
Opzelura Cream
Product Images NDC 50881-007
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Opzelura (NDC 50881-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Incyte Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Opzelura (ruxolitinib) Cream 1.5% (60 g Carton Label)
This is a product description for a cream containing ruxolitinib, manufactured by Opzelurar L. The cream is for topical use only and is recommended to be applied twice daily to affected areas. Each gram contains 15mg of ruxolitinib, along with additional ingredients such as cetyl alcohol, glyceryl stearate SE, and xanthan gum. The cream should be stored between 20°C - 25°C (68F - 77°F) and kept out of reach of children.*
Opzelura (ruxolitinib) Cream 1.5% (60 g Tube Label)
Opzelura cream is a prescription drug with NDC 50881-007-07, containing 1.5% Ruxolitinib. It is a topical cream meant for external use only. The recommended dosage is to apply twice daily to affected areas. Each gram of Opzelura cream contains 15 mg of Ruxolitinib in a mixture of different ingredients. Opzelura cream must be stored between 20°C to 25°C; however, it can tolerate excursions from 15°C to 30°C. Keep away from children and tightly close the tube. It is manufactured by Incyte Corporation in Wilmington, DE, USA. Unfortunately, there is no information available about Lot & EXP.*
Opzelura (ruxolitinib) Cream 1.5% Sample (5 g Carton Label)
This is a description for a cream called Opzelurar, containing 1.5% of ruxolitinib. It is recommended for topical use only and should be applied twice daily to affected areas. It contains several ingredients including cetyl alcohol, dimethicone, mineral oil, polyethylene glycol, and propylene glycol. The cream is manufactured for a company but the name of the company is not mentioned. A dosage recommendation is included, and the storage instructions indicate that the cream should be kept at a temperature between 20°C and 25°C. The text also includes several unreadable characters, indicating errors.*
Opzelura (ruxolitinib) Cream 1.5% Sample (5 g Tube Label)
Opzelura (ruxolitinib) cream 1.5% is a prescription medicine used for topical application only to affected areas. It comes in a 60g tube and is recommended to be applied twice daily. Each gram contains 15 mg of ruxolitinib in a cream that includes various ingredients. The medicine should be stored within 20°C - 25°C (68°F - T7°F) and must be kept out of reach of children. The lot and expiration date are represented on the crimp of the tube.*
Opzelura 6
Opzelura cream 1.5% is a prescription medication used topically only for skin treatment. It contains 15 mg of ruxolitinib per gram of cream and is recommended to be applied twice daily to affected areas. The cream contains various ingredients, and it must be kept at the required storage temperature, and the tube must be tightly closed. This medicine is not for oral, intravaginal, or ophthalmic use, and its prescription information must be read before use.*
Opzelura 7
Opzelura (ruxolitinib) cream 1.5% is a prescription topical medication with NDC 50881-007-04. The recommended dosage for Opzelura is available in the prescribing information. The cream should be stored at controlled room temperature between 20°C - 25°C (68°F - TT°F) with excursions permitted to 15°C - 30°C (59°F - 86°F). Opzelura cream is manufactured for Incyte Corporation located in Wilmington, DE 19803, USA. Lot and expiration date are available on the crimp.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
